qr-010
Nucleic acidexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02532764)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- qr-010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02564354 | Phase 1 | Sep 1, 2015 | European Commission, ProQR Therapeutics, University of Cincinnati |
| NCT02532764 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2015 | European Commission, ProQR Therapeutics, Queen's University, Belfast |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Commission | Government | 2 | 0 | 2 | 2015 |
| ProQR Therapeutics | For profit | 2 | 2 | 2 | 2015 |
| Queen's University, Belfast | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Cincinnati | Academic/Hospital | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1